AusPAR: Galcanezumab

Australian Public Assessment Report

AusPAR

AusPAR: Galcanezumab [PDF, 2.9 MB]

AusPAR: Galcanezumab [Word, 5.16 MB]

Attachment: Product Information: Galcanezumab [PDF, 495.43 KB]

Attachment: Product Information: Galcanezumab [Word, 382.43 KB]

Device/Product Name

Emgality

Active ingredients

Galcanezumab

AusPAR Date

10 September 2019

Published

2 October 2019

Submission Number

PM-2018-00780-1-1

Submission Type

New biological entity

Decision

Approved